Spirulina platensis supplementation, macrophage inhibitory cytokine-1 (MIC-1), oxidative stress markers and anthropometric features in obese individuals: A randomized controlled trial

Journal of Herbal Medicine

Volumn 17-18, Issue , 2019, Pages

  Shariat, Atefeh ^a   Abbasalizad Farhangi, Mahdieh ^b   Zeinalian, Reihaneh ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Appetite; Glutathione peroxidase (GPX); Macrophage inhibitory cytokine 1(MIC 1); Obesity; platensis; Spirulina; Superoxide dismutase (SOD)

Indexed keywords

GLUTATHIONE PEROXIDASE; GROWTH DIFFERENTIATION FACTOR 15; NUTRITION SUPPLEMENT; SUPEROXIDE DISMUTASE;

ADULT; ANTHROPOMETRIC PARAMETERS; APPETITE; ARTHROSPIRA PLATENSIS; ARTICLE; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NUTRITIONAL ASSESSMENT; OBESE PATIENT; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE;

EID: 85063319738     PISSN: 22108033     EISSN: 22108041     Source Type: Journal    
DOI: 10.1016/j.hermed.2019.100264     Document Type: Article

References (38)

1. Aggarwal, A., Aggarwal, S., Sharma, V., Cardiovascular risk factors in young patients of coronary artery disease: differences over a decade. J. Cardiovasc. Thorac. Res. 6:3 (2014), 169–173.
2. Azizi, H., Asadollahi, K.H., Esmaeili, E.D., Mirzapoor, M., Iranian dietary patterns and risk of colorectal cancer. Health. Prom. Perspect. 5:1 (2015), 72–80.
3. Banji, D., Banji, O.J., Pratusha, N.G., Annamalai, A.R., Investigation on the role of Spirulina platensis in ameliorating behavioural changes, thyroid dysfunction and oxidative stress in offspring of pregnant rats exposed to fluoride. Food Chem. 140:1-2 (2013), 321–331.
4. Breit, S.N., Johnen, H., Cook, A.D., Tsai, V.W., Mohammad, M.G., Kuffner, T., Zhang, H.P., Marquis, C.P., Jiang, L., Lockwood, G., Lee-Ng, M., Husaini, Y., Wu, L., Hamilton, J.A., Brown, D.A., The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 29:5 (2011), 187–195.
5. Chuengsamarn, S., Rattanamongkolgul, S., Phonrat, B., Tungtrongchitr, R., Jirawatnotai, S., Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. J. Nutr. Biochem. 25:2 (2014), 144–150.
6. Dartsch, P.C., Antioxidant potential of selected Spirulina platensis preparations. Phytother. Res. 22:5 (2008), 627–633.
7. Dostalova, I., Roubicek, T., Bartlova, M., Mraz, M., Lacinova, Z., Haluzikova, D., Kavalkova, P., Matoulek, M., Kasalicky, M., Haluzik, M., Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur. J. Endocrinol. 161:3 (2009), 397–404.
8. Ebrahimi-Mameghani, M., Mehrabi, E., Kamalifard, M., Yavarikia, P., Correlation between body mass index and central adiposity with pregnancy complications in pregnant women. Health. Prom. Perspect. 3:1 (2013), 73–79.
9. Esteghamati, A., Mazaheri, T., Vahidi-Rad, M., Noshad, S., Complementary and alternative medicine for the treatment of obesity: a critical review. Int. J. Endocrinol. Metab., 13(2), 2015 e19678.
10. Farhangi, M.A., Keshavarz, S.A., Eshraghian, M., Ostadrahimi, A., Saboor-Yaraghi, A.A., Vitamin A supplementation, serum lipids, liver enzymes and C-reactive protein concentrations in obese women of reproductive age. Ann. Clin. Biochem. 50 (2013), 25–30.
11. Farhangi, M.A., Dehghan, P., Tajmiri, S., Abbasi, M.M., The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) – 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial. BMC Complement. Alternat. Med. 16 (2016), 471–480.
12. Fujimoto, M., Tsuneyama, K., Fujimoto, T., Selmi, C., Gershwin, M.E., Shimada, Y., Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. Liver. Dis. 9 (2012), 767–774.
13. Hardeman, W., Griffin, S., Johnston, M., Kinmonth, A.L., Wareham, N.J., Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int. J. Obes. Relat. Metab. Disord. 24:2 (2000), 131–143.
14. Hasani-Ranjbar, S., Zahedi, H.S., Abdollahi, M., Larijani, B., Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders. J. Diabetes Metab. Disord., 12(1), 2013, 49.
15. Hasler, C.M., Functional foods: benefits, concerns and challenges-a position paper from the american council on science and health. J. Nutr. 132:12 (2002), 3772–3781.
16. Kempf, T., Guba-Quint, A., Torgerson, J., Magnone, M.C., Haefliger, C., Bobadilla, M., Wollert, K.C., Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur. J. Endocrinol. 167:5 (2012), 671–678.
17. Khan, Z., Bhadouria, P., Bisen, P.S., Nutritional and therapeutic potential of Spirulina. Curr. Pharm. Biotechnol. 6:5 (2005), 373–379.
18. Kredel, L.I., Siegmund, B., Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front. Immunol., 5, 2014, 462.
19. Layam, A., Reddy, C.L.K., Antidiabetic property of spirulina. Diabetol. Croat. 35 (2007), 27–48.
20. Lee, E.H., Parck, J.E., Choi, Y.J., Huh, K.B., Kin, W.Y., A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr. Res. Pract. 2 (2008), 295–300.
21. Liu, Y., Sun, M., Yao, H., Liu, Y., Gao, R., Herbal medicine for the treatment of obesity: an overview of scientific evidence from 2007 to 2017. Evid. Complement. Alternat. Med., 2017, 2017 Article ID 8943059.
22. Maranesi, M., Barzanti, V., Carenini, G., Gentili, P., Nutritional studies on Spirulina maxima. Acta Vitaminol. Enzymol. 6:4 (1983), 295–304.
23. Martin, S.S., Qasim, A., Reilly, M.P., Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J. Am. Coll. Cardiol. 52:15 (2008), 1201–1210.
24. Mazokopakisa, E.E., Papadomanolakic, M.G., Fousterisd, A.A., Kotsirisa, D.A., Lampadakisa, I.M., Ganotakisb, E.S., The hepatoprotective and hypolipidemic eff ects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study. Ann. Gastroenterol. 27 (2014), 1–8.
25. Mead, E., Atkinson, G., Richter, B., Inti Metzendorf, M., Baur, L., Finer, N., Corpeleijn, E., O'Malley, C., Louisa, J.E., Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst. Rev. 29:16 (2016), 110–116.
26. Miczke, A., Szulinska, M., Hansdorfer-Korzon, R., Krrgielska-Narożna, M., Suliburska, J., Walkowika, J., Bogdanski, P., Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a doubleblind, placebo-controlled, randomized trial. Eur. Rev. Med. Pharmacol. Sci. 20 (2016), 150–156.
27. Moura, L.P., Puga, M.G., Wladimir, R.B., Teixeira, I.P., Ghezzi, C., Silva, A.G., Exercise and spirulina control nonalcoholic hepatic steatosis and lipid profile in diabetic Wistar rats. Lipid. Health. Dis. 10 (2011), 77–89.
28. Myers, M.G., Cowley, M.A., Munzberg, H., Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70 (2008), 537–556.
29. Pezeshkian, M., Darbin, A., Rashidi, M.R., Vatankhah, A., Golmohammadi, Z., Afrasiabi, A., The effect of atherogenic diet with or without enzyme inhibitors on the incidence and progress of atherosclerosis in rabbits. J. Cardiovasc. Thorac. Res. 3:1 (2011), 7–10.
30. Piñero-Estrada, J.E., Bermejo-Bescós, P., Villardel-Fresno, A.M., Antioxidant activity of different fractions of Spirulina platensis protean extract. Farmaco. 56:5-7 (2001), 497–500.
31. Piya, M.K., Harte, A.L., Mc-Ternan, P.G., Metabolic endotoxaemia: is it more than just a gut feeling?. Curr. Opin. Lipidol. 24:1 (2013), 78–85.
32. Ramamoorthy, A., Premakumari, S., Effect of supplementation of Spirulina on hypercholesterolemic patients. J. Food. Sci. Technol. (Mysore), 33(2), 1996, 4.
33. Silva, S.A., Gobbo, M.G., Pinto-Fochi, M.E., Rafacho, A., Taboga, S.R., Almeida, E.A., Goes, R.M., Ribeiro, D.L., Prostate hyperplasia caused by long‐term obesity is characterized by high deposition of extracellular matrix and increased content of MMP‐9 and VEGF. Int. J. Exp. Biol. 96:1 (2015), 21–30.
34. Smeets, A.J., Westerterp-Plantenga, M.S., Acute effects on metabolism and appetite profile of one meal difference in the lower range of meal frequency. Br. J. Nutr. 99:6 (2008), 1316–1321.
35. Sokhanvar, S., Mazaki, R.R.S., Mousavinasab, N., Golmohammadi, Z., The association between serum lipoprotein (a) and other cardiac risk factors with the severity of coronary artery disease. J. Cardiovasc. Thorac. Res. 3:1 (2011), 35–39.
36. Torres-Duran, P.V., Ferreira-Hermosillo, A., Juarez-Oropeza, M.A., Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report. Lipid. Health. Dis. 6 (2007), 33–41.
37. World Health Organization (WHO), Obesity and Overweight (Fact Sheets). Retrieved 16-February- 2018, from, 2016 https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
38. Zeinalian, R., Farhangi, M.A., Shariat, A., Saghafi-Asl, M., The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial. BMC Complement. Altern. Med. 17:1 (2017), 225–228.